Contrary to the above findings, some clinical investigations have reported that CLDN4 is an effective inhibitor of the invasive and metastatic phenotype of PC cells [84,85,86], which confirms the dual role of CLDN4 in the development of this malignancy [72]. The gene discussed is CLDN4; the disease is pachyonychia congenita.